| |
|
|
|
Xtalks, online
2023 -5-23
Clinical trials are an important healthcare option, presenting benefits to patients, physicians and the broader community. Yet, relatively low enrollment rates have continued to be a bottleneck for clinical trials. In traditional research settings, about four percent of the US population has participated in a trial, of which only six percent represent Black and Latinx populations, even though those groups make up nearly 30 percent of the US population. Innovative and scalable solutions that are industry compliant are needed to make equity a reality, thus bringing clinical trial access to underserved populations.
This webinar will provide an opportunity to discover a model that provides clinical trial access to previously under-represented and underserved populations while removing barriers and unlocking doors to innovation. Imagine a trial that adjusts to patients’ schedules, travel capabilities and daily life obligations.
Join featured speakers from PPD and EmVenio Research as they lead a discussion of how localization — learning and adapting to a community’s local language, culture and traditions — has and can increase trial awareness, and clinical trial access to patients everywhere, making equity a reality, leading to an improved patient experience.
Register now to join the discussion on increasing study enrollment, enabling greater diversity and thinking differently about engaging underserved populations.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
John Manns, Senior Director, Consultancy, Innovation & Strategy, Digital and Decentralized Solutions, PPD Thad Wolfram, President, EmVenio Research Niambi Blodgett, Director, Global Patient Engagement, EmVenio Research
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -5-23
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|